Terahertz's silent revolution in physics, engineering, and life science: Beyond the spectrum.

Fundamental research · 2025 · Unclear · Insufficient evidence

← Research stream

UnclearInsufficient evidencePaper 2403

Study snapshot

PublicationFundamental research · 2025

Study typereview

Reported directionUnclear

Evidence ratingInsufficient

Abstract

Terahertz technology is revolutionizing photonics, biomedicine, and communications by merging non-ionizing radiation with molecular sensitivity and material penetration. Advances in metamaterials, adaptive antennas, and AI-driven systems address historical limitations in emission efficiency and atmospheric attenuation, enabling secure high-capacity networks and precision biomedical applications. Reconfigurable beamforming and hybrid channel models enhance wireless reliability, while ultra-sensitive biosensors and neuromodulation techniques pioneer non-invasive diagnostics and therapies for neurodegenerative and psychiatric disorders. Terahertz's dual role in molecular sensing and neural modulation establishes closed-loop "detect-treat" paradigms, bridging material science and neuroscience. Challenges remain in optimizing clinical application and hybrid system scalability, yet its capacity to probe carrier dynamics, protein interactions, and neural circuits positions Terahertz as a universal platform for 6G networks, personalized medicine, and brain-machine interfaces. By unifying physics-aware engineering with biological insights, terahertz technology transcends traditional boundaries, offering transformative solutions for healthcare, secure connectivity, and industrial innovation.

Machine Enhanced Logic

AI evidence extraction

Structured fields below were generated from the paper’s abstract and metadata to make the evidence easier to inspect. Automated extraction may be incomplete or incorrect; verify important details against the original paper.

Study typereview

Effect directionunclear

PopulationNot supplied

Sample sizeNot supplied

ExposureTHz

Evidence strengthInsufficientConfidence: 66% · Peer reviewed: yes

Main findings

The review describes terahertz technology developments (e.g., metamaterials, adaptive antennas, AI-driven systems) that improve emission efficiency and mitigate atmospheric attenuation, supporting high-capacity wireless networks. It also highlights emerging biomedical applications including ultra-sensitive biosensing and neuromodulation approaches aimed at non-invasive diagnostics and therapies, while noting remaining challenges in clinical optimization and scalability.

Outcomes measured

wireless communications performance (e.g., secure high-capacity networks, reliability)
biomedical sensing/diagnostics (e.g., biosensors, molecular/protein interactions)
neuromodulation applications (non-invasive diagnostics/therapies; neurodegenerative and psychiatric disorders)

Limitations

No specific study designs, exposure parameters (frequency, SAR), populations, or quantitative results are provided in the abstract.
The abstract is broad and technology-forward, limiting inference about health effects or safety outcomes.

View raw extracted JSON

{
  "study_type": "review",
  "exposure": {
    "band": "THz",
    "source": null,
    "frequency_mhz": null,
    "sar_wkg": null,
    "duration": null
  },
  "population": null,
  "sample_size": null,
  "outcomes": [
    "wireless communications performance (e.g., secure high-capacity networks, reliability)",
    "biomedical sensing/diagnostics (e.g., biosensors, molecular/protein interactions)",
    "neuromodulation applications (non-invasive diagnostics/therapies; neurodegenerative and psychiatric disorders)"
  ],
  "main_findings": "The review describes terahertz technology developments (e.g., metamaterials, adaptive antennas, AI-driven systems) that improve emission efficiency and mitigate atmospheric attenuation, supporting high-capacity wireless networks. It also highlights emerging biomedical applications including ultra-sensitive biosensing and neuromodulation approaches aimed at non-invasive diagnostics and therapies, while noting remaining challenges in clinical optimization and scalability.",
  "effect_direction": "unclear",
  "limitations": [
    "No specific study designs, exposure parameters (frequency, SAR), populations, or quantitative results are provided in the abstract.",
    "The abstract is broad and technology-forward, limiting inference about health effects or safety outcomes."
  ],
  "evidence_strength": "insufficient",
  "confidence": 0.66,
  "peer_reviewed_likely": "yes",
  "keywords": [
    "terahertz",
    "non-ionizing radiation",
    "metamaterials",
    "adaptive antennas",
    "AI-driven systems",
    "atmospheric attenuation",
    "beamforming",
    "hybrid channel models",
    "biosensors",
    "molecular sensing",
    "neuromodulation",
    "detect-treat",
    "6G",
    "personalized medicine",
    "brain-machine interfaces"
  ],
  "suggested_hubs": [
    {
      "slug": "6g",
      "weight": 0.78,
      "reason": "Discusses terahertz as a platform for 6G networks and high-capacity secure connectivity."
    }
  ]
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract and metadata and may be incomplete or incorrect. This material is for informational purposes and is not medical advice.

Identifiers and source

DOI: 10.1016/j.fmre.2025.05.004
PubMed: 41613455

Read the original paper →

Related papers

← Back to the Research Library